Skip to main content
. 2021 May 6;16(5):e0247357. doi: 10.1371/journal.pone.0247357

Table 1. Baseline demographics.

Placebo SP16 0.0125 mg/g SP 16 0.050 mg/kg SP16 0.200 mg/kg P-value
Number of subjects 6 6 6 6 N/A
Age, years (IQR) 37 (21, 48) 21 (21, 32) 35 (25,42) 23 (20, 27) 0.07
Female (%) 4 (67%) 3 (50%) 2 (33%) 2 (33%) 0.60
non-Hispanic, n (%) 6 (100%) 6 (100%) 6 (100%) 6 (100%) 1
Caucasian, n (%) 3 (50%) 3 (50%) 5 (83%) 5 (83%) 0.51
Asian, n (%) 1 (17%) 2 (33%) 1 (17%) 1 (17%)
Black, n (%) 2 (33% 1 (17%) 0 (0%) 0 (0%)
Height, cm (IQR) 167 (161, 175) 168 (162, 177) 170 (163, 182) 171 (166, 182) 0.75
Weight, kg (IQR) 76 (68, 92) 69 (58, 71) 65 (58, 81) 73 (64, 98) 0.27
HR, bpm (IQR) 78 (71, 84) 65 (53, 81) 69 (53, 79) 76 (67, 87) 0.29
Systolic BP, mmHg (IQR) 121 (106, 130) 123 (105, 127) 115 (105, 127) 124 (117, 133) 0.69
Diastolic BP. mmHg (IQR) 74 (65, 82) 76 (68, 83) 70 (65, 80) 77 (74, 85) 0.59

BP = blood pressure, bpm = beats per minute, cm = centimeter, kg = kilogram, IQR = interquartile range n = Number, mmHg = millimeter of mercury